Showing results (91-100 of 185) with videos related to
Sort By:
Pageof 19
Current Medicinal Chemistry. Anti-Cancer Agents|February 3, 2004
Multidrug resistance in cancer chemotherapy and xenobiotic protection mediated by the half ATP-binding cassette transporter ABCG2B Han, J-T ZhangCurrent Medicinal Chemistry. Anti-Cancer Agents|September 24, 2004
Monoclonal antibodies in cancer therapyBarbara GattoCurrent Medicinal Chemistry. Anti-Cancer Agents|September 24, 2004
Novel molecular targets in cancer chemotherapy waiting for discoveryConrad KunickCurrent Medicinal Chemistry. Anti-Cancer Agents|September 24, 2004
Camptothecins and topoisomerase I: a foot in the door. Targeting the genome beyond topoisomerase I with camptothecins and novel anticancer drugs: importance of DNA replication, repair and cell cycle checkpointsYves PommierCurrent Medicinal Chemistry. Anti-Cancer Agents|September 24, 2004
Combining DNA damaging agents and checkpoint 1 inhibitorsMichelle PrudhommeCurrent Medicinal Chemistry. Anti-Cancer Agents|September 24, 2004
Resistance in cancer: a target for drug discoveryMark Searcey, Laurence H PattersonCurrent Medicinal Chemistry. Anti-Cancer Agents|February 22, 2005
Novel anticancer targets and drug discovery in post genomic ageQianbin Li, Wenfang XuCurrent Medicinal Chemistry. Anti-Cancer Agents|November 25, 2005
Lanthanides as anticancer agentsIrena KostovaCurrent Medicinal Chemistry. Anti-Cancer Agents|November 25, 2005
Current drug therapy for prostate cancer: an overviewAlistair B Stewart, Bashir A Lwaleed, David A Douglas, et al.Current Medicinal Chemistry. Anti-Cancer Agents|May 29, 2003
Bcl-2 proteins: targets and tools for chemosensitisation of tumor cellsAli Bettaieb, Laurence Dubrez-Daloz, Sophie Launay, et al.Pageof 19